– USA, NJ – MTBC, a leading provider of cloud-based electronic health records, practice management, revenue cycle management and patient engagement solutions, today announced the appointment of John N. Daly, a former Executive Vice President and Director at E.F. Hutton, to its Board of Directors.
Mr. Daly has over 50 years of experience in the financial services industry, beginning with 23 years at E.F. Hutton, where he served as an Executive Vice President and member of the Board of Directors. Thereafter, Mr. Daly worked at Salomon Brothers, both in New York and London, where he headed the Private Client Division and International Equity Capital Markets.
“We are pleased to welcome Mr. Daly to MTBC’s Board of Directors,” remarked Mahmud Haq, Chairman of the Board. “Mr. Daly’s guidance will be invaluable as we continue to grow and pursue an Initial Public Offering (IPO).”
MTBC filed a draft registration statement with the SEC on September 9, 2013.
John N. Daly was awarded his degree from Yale University and completed the Harvard Business School Advanced Management Program in 1979.
Founded in 1999 and based in Somerset, New Jersey, MTBC provides practice and revenue cycle management services and proprietary software solutions to private physician offices and hospital-employed provider groups throughout the United States. Its integrated and competitively priced premium products, PracticePro™ and ChartsPro™, present a service suite unmatched in the industry in scope and value. MTBC has been consistently recognized as a Deloitte Technology Fast 500 company – 2009, 2010, 2011 and 2012 – and has also been recognized during each of the last three years as an Inc. 500│5000 company.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.